Human Genome Epidemiology Literature Finder
|
Records 1 - 18 (of 18 Records) |
| Query Trace: Hyperprolactinemia and DRD2[original query] |
|---|
| Relationship between Taq1 A dopamine D2 receptor (DRD2) polymorphism and prolactin response to bromperidol. American journal of medical genetics 2001 Apr 105 (3): 271-4. Mihara K, Suzuki A, Kondo T, Yasui-Furukori N, Ono S, Otani K, Kaneko S, Inoue |
| The dopamine receptor D2 genotype is associated with hyperprolactinemia. Fertility and sterility 2005 Sep 84 (3): 711-8. Hansen Keith A, Zhang Yueyi, Colver Robert, Tho Sandra P T, Plouffe Leo, McDonough Paul |
| CYP2D6 and DRD2 genes differentially impact pharmacodynamic sensitivity and time course of prolactin response to perphenazine. Pharmacogenetics and genomics 2007 Nov 17 (11): 989-93. Aklillu Eleni, Kalow Werner, Endrenyi Laszlo, Harper Patricia, Miura Jun, Ozdemir Vur |
| Association between dopamine-related polymorphisms and plasma concentrations of prolactin during risperidone treatment in schizophrenic patients. Progress in neuro-psychopharmacology & biological psychiatry 2008 Aug 32 (6): 1491-5. Yasui-Furukori Norio, Saito Manabu, Tsuchimine Shoko, Nakagami Taku, Sato Yasushi, Sugawara Norio, Kaneko Sun |
| Variants of the dopamine D2 receptor gene and risperidone-induced hyperprolactinemia in children and adolescents. Pharmacogenetics and genomics 2009 May 19 (5): 373-82. Calarge Chadi A, Ellingrod Vicki L, Acion Laura, Miller Del D, Moline Jessica, Tansey Michael J, Schlechte Janet |
| Genetic associations of prolactin increase in olanzapine/fluoxetine combination-treated patients. Psychiatry research 2010 Jan 175 (1-2): 171-2. Houston John P, Fijal Bonnie, Heinloth Alexandra N, Adams David |
| DRD2 Taq1A polymorphism modulates prolactin secretion induced by atypical antipsychotics in healthy volunteers. Journal of clinical psychopharmacology 2011 Oct 31 (5): 555-62. López-Rodríguez Rosario, Román Manuel, Novalbos Jesús, Pelegrina Maria Laura, Ochoa Dolores, Abad-Santos Francis |
| The effect of the Taq1A variant in the dopamine D2 receptor gene and common CYP2D6 alleles on prolactin levels in risperidone-treated boys. Pharmacogenetics and genomics 2013 Sep 23 (9): 487-93. Roke Yvette, van Harten Peter N, Franke Barbara, Galesloot Tessel E, Boot Annemieke M, Buitelaar Jan |
| Polymorphic variants in the dopamine receptor D2 in women with endometriosis-related infertility. Molecular medicine reports 2015 Aug 12 (2): 3055-60. Szczepa?ska Malgorzata, Mostowska Adrianna, Wirstlein Przemyslaw, Skrzypczak Jana, Misztal Matthew, Jagodzi?ski Pawe? |
| Hyperprolactinemia in Children and Adolescents with Use of Risperidone: Clinical and Molecular Genetics Aspects. Journal of child and adolescent psychopharmacology 2015 Dec 25 (10): 738-48. Dos Santos Júnior Amilton, Henriques Taciane Barbosa, de Mello Maricilda Palandi, Neto Adriana Perez Ferreira, Paes Lúcia Arisaka, Torre Osmar Henrique Della, Sewaybricker Letícia Esposito, Fontana Thiago Salum, Celeri Eloisa Helena Rubello Valler, Júnior Gil Guerra, Dalgalarrondo Pau |
| Variants in the DRD2 locus and antipsychotic-related prolactin levels: A meta-analysis. Psychoneuroendocrinology 2016 Jun 72 1-10. Miura Itaru, Zhang Jian-Ping, Hagi Katsuhiko, Lencz Todd, Kane John M, Yabe Hirooki, Malhotra Anil K, Correll Christoph |
| Relation between serum prolactin levels and antipsychotic response to risperidone in patients with schizophrenia. Psychiatry research 2016 Apr 240 209-213. Charan Alladi, Shewade Deepak Gopal, Rajkumar Ravi Philip, Chandrasekaran Adith |
| Impact of Pharmacogenetic Markers of CYP2D6 and DRD2 on Prolactin Response in Risperidone-Treated Thai Children and Adolescents With Autism Spectrum Disorders. Journal of clinical psychopharmacology 2016 Feb . Sukasem Chonlaphat, Hongkaew Yaowaluck, Ngamsamut Nattawat, Puangpetch Apichaya, Vanwong Natchaya, Chamnanphon Montri, Chamkrachchangpada Bhunnada, Sinrachatanant Ananya, Limsila Penkh |
| Risperidone-Induced Adverse Drug Reactions and Role of DRD2 (-141 C Ins/Del) and 5HTR2C (-759 C>T) Genetic Polymorphisms in Patients with Schizophrenia. Journal of pharmacology & pharmacotherapeutics 0 8 (1): 28-32. Alladi Charanraj Goud, Mohan Anbarasan, Shewade Deepak Gopal, Rajkumar Ravi Philip, Adithan Surendiran, Subramanian Karthi |
| Impact of NTRK2, DRD2 and ACE polymorphisms on prolactin levels in antipsychotic-treated patients with first-episode psychosis. Journal of psychopharmacology (Oxford, England) 2018 May 269881118773026. Gassó Patricia, Mas Sergi, Bioque Miquel, Cabrera Bibiana, Lobo Antonio, González-Pinto Ana, Díaz-Caneja Covadonga M, Corripio Iluminada, Vieta Eduard, Castro-Fornieles Josefina, Sarró Salvador, Mané Anna, Sanjuan Julio, Llerena Adrián, Lafuente Amalia, Saiz-Ruiz Jerónimo, Bernardo Miguel, |
| A pharmacogenetic study of patients with schizophrenia from West Siberia gets insight into dopaminergic mechanisms of antipsychotic-induced hyperprolactinemia. BMC medical genetics 2019 Apr 20 (Suppl 1): 47. Osmanova Diana Z, Freidin Maxim B, Fedorenko Olga Yu, Pozhidaev Ivan V, Boiko Anastasiia S, Vyalova Natalia M, Tiguntsev Vladimir V, Kornetova Elena G, Loonen Anton J M, Semke Arkadiy V, Wilffert Bob, Bokhan Nikolay A, Ivanova Svetlana |
| Association of ANKK1 polymorphism with antipsychotic-induced hyperprolactinemia. Human psychopharmacology 2020 May e2737. Fedorenko Olga Yu, Paderina Diana Z, Loonen Anton J M, Pozhidaev Ivan V, Boiko Anastasiia S, Kornetova Elena G, Bokhan Nikolay A, Wilffert Bob, Ivanova Svetlana |
| Pharmacogenomic Studies in Intellectual Disabilities and Autism Spectrum Disorder: A Systematic Review. Canadian journal of psychiatry. Revue canadienne de psychiatrie 2020 11 66 (12): 1019-1041. Yoshida Kazunari, Koyama Emiko, Zai Clement C, Beitchman Joseph H, Kennedy James L, Lunsky Yona, Desarkar Pushpal, Müller Daniel |
- Page last reviewed:Feb 1, 2024
- Content source: